United Therapeutics
UTHR
#1090
Rank
NZ$37.18 B
Marketcap
NZ$822.19
Share price
-0.87%
Change (1 day)
26.98%
Change (1 year)

Market capitalization of United Therapeutics (UTHR)

Market cap: NZ$37.18 Billion

As of January 2026 United Therapeutics has a market cap of NZ$37.18 Billion. This makes United Therapeutics the world's 1090th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of United Therapeutics from 1999 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$37.18 B-6.11%
2025NZ$39.60 B38.99%
2024NZ$28.49 B74.39%
2023NZ$16.34 B-18.15%
2022NZ$19.96 B40.12%
2021NZ$14.24 B52.39%
2020NZ$9.34 B62.89%
2019NZ$5.73 B-18.9%
2018NZ$7.07 B-21.39%
2017NZ$9.00 B2.49%
2016NZ$8.78 B-16.12%
2015NZ$10.47 B34.5%
2014NZ$7.78 B12.28%
2013NZ$6.93 B112.85%
2012NZ$3.25 B-7.76%
2011NZ$3.53 B-25.12%
2010NZ$4.71 B20%
2009NZ$3.93 B56.98%
2008NZ$2.50 B-11.72%
2007NZ$2.83 B71.13%
2006NZ$1.65 B-29.72%
2005NZ$2.35 B66.16%
2004NZ$1.41 B88.63%
2003NZ$0.75 B12.69%
2002NZ$0.66 B31.68%
2001NZ$0.50 B-25.45%
2000NZ$0.68 B-51.72%
1999NZ$1.40 B

End of Day market cap according to different sources

On Jan 13th, 2026 the market cap of United Therapeutics was reported to be:

NZ$35.71 Billion
by Nasdaq info icon info icon
NZ$37.51 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Eli Lilly
LLY
NZ$1.663 T 4,373.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$266.30 B 616.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$64.63 B 73.83%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Pfizer
PFE
NZ$252.33 B 578.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
NZ$17.60 B-52.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
NZ$13.59 B-63.44%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$177.33 B 376.90%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cardinal Health
CAH
NZ$88.12 B 137.00%๐Ÿ‡บ๐Ÿ‡ธ USA